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Abstract
Since 2002, information on individual microRNAs (miRNAs), such as reference names
and sequences, has been stored in miRBase, the reference database for miRNA annota-
tion. As a result of progressive insights into the miRNome and its complexity, miRBase
underwent addition and deletion of miRNA records, changes in annotated miRNA se-
quences and adoption of more complex naming schemes over time. Unfortunately,
miRBase does not allow straightforward assessment of these ongoing miRNA annota-
tion changes, which has resulted in substantial ambiguity regarding miRNA identity and
sequence in public literature, in target prediction databases and in content on various
commercially available analytical platforms. As a result, correct interpretation, compari-
son and integration of miRNA study results are compromised, which we demonstrate
here by assessing the impact of ignoring sequence annotation changes. To address this
problem, we developed miRBase Tracker (www.mirbasetracker.org), an easy-to-use on-
line database that keeps track of all historical and current miRNA annotation present in
the miRBase database. Three basic functionalities allow researchers to keep their miRNA
annotation up-to-date, reannotate analytical miRNA platforms and link published results
with outdated annotation to the latest miRBase release. We expect miRBase Tracker to
increase the transparency and annotation accuracy in the field of miRNA research.
Database URL:www.mirbasetracker.org
Introduction
MicroRNAs (miRNAs) represent the most widely studied
class of noncoding RNA molecules. Since their discovery in
1993, the number of scientific reports on miRNAs has
increased exponentially (1) and a role as crucial gene ex-
pression regulators involved in numerous aspects of both
the normal and the diseased cell’s physiology has been
demonstrated in many organisms. In the canonical miRNA
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pathway, mature miRNAs are processed from hairpin pre-
cursors and guide an effector protein complex, named
miRISC, to regions of partial or complete complementarity
in target mRNA molecules. miRISC complexes subse-
quently exert the miRNA-mediated repression by inducing
destabilization, degradation or translational inhibition of
target molecules (2).
The pivotal role of miRNAs in regulating gene expres-
sion is reflected by various achievements in biomedical
research and human medicine, and the impact they are
starting to have on patient management. Cases in point are
the development of diagnostic and prognostic miRNA ex-
pression signatures for various human pathologies (3), and
the prospect of miRNA-based therapeutics for viral dis-
eases and cancer (3), with hsa-miR-34a-5p replacement
therapy in liver cancer patients entering clinical trials (4)
and antisense agents directed against hsa-miR-122-5p
at the doorstep of market approval for treating hepatitis C
infection (5).
The miRBase database is highly dynamic
With the development of the miRBase database, the
Wellcome Trust Sanger Institute initiated an effort to un-
ambiguously annotate miRNAs and to enable unified use
of miRNA sequences throughout the research community
(1, 6, 7). The miRBase database, originally the miRNA
registry, has been the reference database for miRNA anno-
tation since 2002 (8). It provides a central place for collect-
ing all known precursor and mature miRNA sequences,
along with primary evidence for their existence. In add-
ition, miRBase has put forward the miRNA nomenclature
conventions that have been accepted by the research
community.
Mainly as a result of the increasing number of small
RNA sequencing efforts, the database has grown exponen-
tially since its initial publication (Figure 1C) (1), going
from 218 precursor and 218 mature miRNAs from five
species annotated in the first release (miRBase release 1.0,
December 2002) to 28 645 precursor and 35828 mature
miRNAs from 223 species annotated in the release at time
of publication (miRBase release 21, June 2014). In add-
ition, technical advances in the field of massively parallel
sequencing, with increasing coverage depths, have not only
led to the detection of miRNAs of ever lower abundance
but also to more reliable sequence annotation.
These evolutions have resulted in an organically grown
database with the number of records as well as their re-
spective contents changing over time. Unfortunately, in its
current database structure, miRBase does not allow
straightforward assessment of these annotation changes,
resulting in ambiguous and erroneous application of
miRNA nomenclature and sequence information in the re-
search community. With miRBase Tracker, we provide a
tool to resolve this ambiguity.
Results
Changing nomenclature creates confusion about
miRNA identity in public literature
‘What’s in a name?’ Shakespeare once wrote. For miRNAs
this certainly holds true. Using only a miRNA’s name to
reference it seems natural, but it comes with various limita-
tions. For one, a miRNA name does not unambiguously
identify a miRNA sequence. A miRNA sequence is under
constant revision and can change as new (more accurate)
data becomes available. In particular cases, the same name
has also been used for different miRNA sequences, as is for
instance the case for the widely studied human mature hsa-
miR-34b (9, 10). For another, miRNA names constantly
evolve, even while remaining associated with the same mol-
ecule. The gradual uncovering of the miRNome’s complex-
ity, with identification of homologous miRNA loci, miRNA
families and the awareness that both strands of the precur-
sor stem can produce functional miRNAs, has required
more complex naming schemes, resulting in changing no-
menclature conventions. The miRBase database has tried to
convey this increasing biological complexity by adding dif-
ferent suffixes to precursor and mature miRNA names.
As researchers typically rely only on names to reference
miRNAs in their publications, this evolution of nomencla-
ture has created a lot of ambiguity, and it is often difficult
to unambiguously identify the miRNA molecule under
study. Linking different publications, target prediction
database entries and commercial research products has
proven to be more deceptive than anticipated, especially
when sequence information is unavailable. This ambiguity
is apparent from the observation that 12% of publications
(Figure 1A) on human mature miRNAs use outdated or in-
correct miRNA names, when referencing to nomenclature
conventions applicable at the time of publication. When
focusing on publications on miRNAs whose name has
been revised at least once at time of publication (44% of
publications), this number even rises to 25%.
Using outdated or incorrect nomenclature hints at an
unawareness of annotation updates or an inability to keep
up with them; it does not imply erroneous research conclu-
sions per se. The resulting miRNA identity ambiguities,
however, at least hamper correct interpretation and com-
parison of independent studies and thus indirectly affect
research quality. Even when a miRNA name can unam-
biguously be linked to a miRNA molecule, caution is still
warranted, as annotated miRNA sequences are not stable,
but can subtly change.
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Ignoring changes in sequence annotation impacts
research outcome
Altered miRNA sequence annotation can be a consequence
of improved sequencing accuracy, but can also reflect true
biological variability. Subtle sequence variants can arise
from homologous miRNA loci or by differential processing
of the product of a single miRNA locus, which are then
called isomiRs (11). Irrespective of its underlying cause, it
is important for researches to be aware of these changing
sequence annotations.
Figure 1. (A) miRNA nomenclature use in public literature. Publications on human mature miRNAs in PubMed were curated for correct use of nomen-
clature. To account for potential incorrect use because of the release of one or multiple miRBase versions during peer review, any of the applicable
conventions up until 12 months before publication (miRBase release transition period) were accepted. (B) miRNA sequence reporting in public litera-
ture. 100 publications on human mature miRNAs were curated for the unambiguous disclosing of miRNA sequences. Accepted reporting was the ma-
ture miRNA sequence itself (e.g. ACAAGUCAGGCUCUUGGGACCU), the miRNA name in combination with the miRBase release (e.g. rno-miR-125b-
2-3p, miRBase 21) or the miRNA accession number in combination with the miRBase release (e.g. MIMAT0026467, miRBase 21). (C) Evolution of
miRBase for human mature miRNA records and the impact of miRNA sequence annotation changes on target prediction.
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A miRNA’s sequence and function are closely linked.
Even a small sequence variation can have a profound
impact on targeting specificity, especially when the new se-
quence comes with a different seed region. Single nucleo-
tide polymorphisms and point mutations in mature
miRNAs have been shown to divert them to other mRNA
targets (12). Furthermore, numerous examples exist of sin-
gle nucleotide changes in 30UTR regions that either create
or disrupt a functional binding site (12). A striking ex-
ample of the tight relationship between sequence and func-
tion is observed in high-grade glioma patients, where
lowered adenosine-to-inosine editing of a single nucleotide
in miR-376a-5p leads to loss of AMFR protein repression
and increased inhibition of RAP2A, which contributes to a
more aggressive disease and correlates with reduced
patient survival (13).
Although it is desirable to report on up-to-date miRNA
sequences, the use of outdated sequences in itself is not
problematic. After all, publications do not suddenly lose
their value upon a miRBase update. Furthermore, it is hard
to claim previously annotated sequences to be erroneous,
with annotation continuously changing, sometimes back
and forth, and with the notion that different versions of an
annotated miRNA sequence might just represent isomiRs.
The problem is founded in ignoring these sequence annota-
tion differences, when comparing studies that actually
investigated slightly different sequences.
A systematic and in-depth assessment of the impact of
ignoring miRNA sequence annotation changes on research
conclusions in literature is difficult. As a surrogate, we as-
sessed how sequence annotation changes affect miRNA
target prediction. Measuring this impact is a relevant alter-
native, as target prediction is generally one of the first steps
undertaken towards obtaining a clue on a given miRNA’s
function. We performed and compared human target pre-
dictions for five different miRBase releases (Figure 1C) and
found between 21 and 36% of nonoverlapping predictions
between any two releases because of sequence changes
alone (not taking into account differential predictions due
to newly added or deleted miRNA records), clearly demon-
strating that ignoring sequence annotation changes drastic-
ally impacts functional miRNA research.
Of note, not all online miRNA target prediction tools
and databases are keeping their miRNA sequence annota-
tion up-to-date. PicTar (14) predictions, for instance, are
still based on the miRBase release 5.0 annotation (2004).
Since then, about half of the human mature miRNA se-
quences annotated in that release (92 of 189) have
changed, 2402 new miRNAs have been added to the data-
base and 3 miRNA records have been deleted (compared
with release 21). Despite being dramatically outdated,
PicTar still remains one of the most widely used algorithms
in the field, with 270 citations in 2013 alone and probably
much more unreferenced use, underscoring many re-
searchers’ unawareness of the problem.
Accession numbers do not solve the problem of
miRNA annotation dynamics
In principle, annotation changes can be overcome by pro-
viding each miRNA specimen with a unique and stable
identifier or accession number, analogous to for instance
the RefSeq system for nucleotide sequence and protein an-
notation (15). Accession numbers for precursor miRNAs
were introduced in the first miRBase release (2002; e.g.
MI0000116 for dme-mir-1), whereas mature miRNA ac-
cession numbers were only introduced in release 6.0 (2005;
e.g. MIMAT0000896 for rno-miR-292-5p). Evidently, as
the information linked to a miRNA record is prone to
change, this identifier only holds unique information when
accompanied by a version number, again much like the
situation for RefSeq records. Unfortunately, the miRBase
accession number system does not include version num-
bers. Therefore, unambiguous reporting of a miRNA can
only be achieved by either disclosing the sequence or, alter-
natively, providing its name or accession number explicitly
in combination with the release version of the miRBase
database. Considering the impact of sequence changes
on miRNA function and research outcome, it is worri-
some that 69 of 100 manually curated articles do not un-
ambiguously report sequences of all investigated miRNAs
(Figure 1B).
miRBase Tracker allows easy tracking of miRNA
annotation changes
As demonstrated above, the organically grown miRBase
has lead to substantial risks of miRNA identity confusion
and ignoring sequence annotation changes. To help re-
searchers keep track of the annotation of their miRNAs of
interest, we developed miRBase Tracker, an easy-to-use
online database and webtool (www.mirbasetracker.org)
that stores all miRBase releases in a logically organized
MySQL database. Three useful query options are presented
to the user.
With a miRNA history query (Figure 2A), the user gets
an overview of the annotation changes of any mature or
precursor miRNA of interest throughout the different
miRBase releases. Searching for a miRNA name, sequence
or accession number will show the evolution of all nomen-
clature, sequence information and other annotation linked
to it over time.
Retrieving the most up-to-date annotation for any pre-
cursor or mature miRNA name, sequence or accession
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Figure 2. miRBase Tracker functionalities. (A) miRNA history query: annotation history of the human mature miRNA ‘hsa-miR-378a-3p’. (B) miRNA
update query: updated annotation (miRBase release 21 at time of publication) of the rat precursor miRNA ‘rno-mir-190’. (C)miRBase release compari-
son query: comparison of miRBase release 9.2 with 17 for mouse mature miRNAs.
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number annotated in any miRBase release can be achieved
by performing a miRNA update query (Figure 2B). If
needed, batch files containing information on multiple
miRNAs can be uploaded, facilitating reannotation of ana-
lytical miRNA platforms and of outdated miRNA gene
lists in literature.
The miRBase release comparison query option
(Figure 2C) compares any two miRBase releases for both
mature and precursor miRNAs within any species. Users
get an overview showing which miRNA records were
added, removed, changed or remained unchanged, along
with summarizing statistics.
Discussion
The information stored in the miRBase reference database
for miRNA annotation is highly dynamic. New records are
added on discovery of new miRNA entities, existing
records are deleted if there is no longer sufficient evidence
for existence of the miRNAs covered and redundant re-
cords covering the same miRNA are merged. Sequences get
revised as additional data become available and nomencla-
ture changes in an effort to convey as much biological
complexity through miRNA naming schemes as possible.
Because the miRBase database structure does not allow
straightforward appreciation of these continuous annota-
tion changes, substantial ambiguity has arisen in the field
of miRNA research, with confusion about miRNA (se-
quence) identity in public literature, in target prediction
databases and on analytical platforms. Companies selling
commercial miRNA research products have further com-
plicated the situation, as they often apply their own no-
menclature, fail to update product annotation or recycle
product IDs, creating a false sense of annotation stability.
Researchers also contribute to the problem, as they fail to
unambiguously report the miRNAs they investigate, mak-
ing it impossible to reliably build on their studies.
Therefore, we would like to encourage miRNA researchers
to no longer solely (and conveniently) rely on miRNA
names, but to also disclose the sequences or, alternatively,
provide the miRNA names or accession numbers explicitly
in combination with the miRBase release version.
Conclusions reported in miRNA literature have most
likely suffered from this ambiguity. Although difficult to
assess, miRNA identity confusion may have led to unjusti-
fied comparison and integration of results from studies
investigating unrelated miRNA sequences. In addition, in
some instances, comparison of study results on (sup-
posedly) identical miRNA molecules has inevitably ignored
subtle sequence annotation changes. As we demonstrate
here, subtle sequence annotation changes can dramatically
impact study conclusions, as on average one-third of the
targetome is expected to change for miRNAs undergoing a
sequence update. Unfortunately, the poor unambiguous se-
quence reporting in literature, together with the wide-
spread use of online target prediction databases relying on
outdated annotation, point at an unawareness of the prob-
lem in the field. Keeping track of correct miRNA annota-
tion and aligning annotation of different data sources
should, however, be considered imperative to high-quality
miRNA research. Although possibly challenging when
integrating high-throughput and/or whole-genome miRNA
data sets, at least when prioritizing miRNAs for further in-
vestigation, it becomes the researcher’s responsibility to
retrospectively verify correct alignment of annotation.
Furthermore, one must always strive to respect the most
up-to-date annotation, as it represents the most accurate
view on the miRNome at any given time.
miRBase Tracker is a framework on top of miRBase
that, in addition to providing miRBase’s basic annotation
information, allows researchers to keep track of miRNA
annotation changes and facilitates reannotation. In the fu-
ture, keeping track of correct miRNA annotation is specu-
lated to become even more challenging owing to the
discovery of isomiRs (11), subtle sequence variants arising
by differential processing of precursor and mature
miRNAs depending on tissue type, developmental stage
and physiological conditions. At present, miRBase ignores
these bona fide variants and miRNAs are annotated as sin-
gle canonical sequences, representing for each miRNA the
predominant isomiR as known to date. Respecting biolo-
gical reality, however, would require miRBase to couple
multiple sequence variants to a single miRNA record. A
context-dependent pursuit of particular isomiRs for indi-
vidual miRNAs will then become the next challenge for the
miRNA researcher. At present, the predominant isomiRs
present in miRBase-curated data sets can change, which—
in addition to improved sequencing accuracy—probably
also partly explains the dynamic in sequence annotation.
Given the prospect of increasing complexity in absence
of a transparent database that allows straightforward as-
sessment of miRNA annotation changes, we believe that
miRBase Tracker will be crucial in overcoming the grow-
ing ambiguity in the field of miRNA research.
Methods
Nomenclature use in public literature
miRNA nomenclature usage in public literature was as-
sessed by means of an automated text-mining ap-
proach similar to the one used for the PubMeth database
(16). Briefly, NCBI’s PubMed database was queried
with every human mature miRNA name—and its textual
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variants—that was ever annotated in the miRBase data-
base (up until release 19), in combination with the MeSH
term ‘human’. 8491 publications were retrieved over a
16-year publication time frame (March 1997–March
2013) (Supplementary Table S1). miRNA nomenclature
used in each publication was then referenced to nomencla-
ture conventions applicable at the time of publication and
in the preceding year.
Sequence reporting in public literature
miRNA sequence reporting in public literature was
manually assessed. 100 publications on human mature
miRNAs were randomly selected over a 3-year publication
time frame (1 July 2010–30 June 2013) (Supplementary
Table S2). Article full-texts, figures and supplementary
files were checked for unambiguous reporting of the se-
quence(s) of the investigated miRNA(s). Accepted report-
ing was either the mature sequence itself or, alternatively,
the name or accession number in combination with a miR-
Base release version.
Differential target prediction
The MirTarget2 (17) algorithm was used to predict 30UTR
targets (RefSeq database release 54) of all human mature
miRNA sequences annotated in five relatively equally
spaced releases of the miRBase database (2.0, 6.0, 9.2,
13.0 and 18). To assess the degree of differential prediction
exclusively attributable to sequence annotation changes,
predictions from newly added or deleted miRNA records
were not considered, and only predictions from records
common to both releases but having a sequence change
were included in the analysis. For any combination of two
releases, prediction overlap was calculated as the ratio of
the number of common interactions to the total number of
unique interactions predicted using both releases.
Database structure and content
miRBase annotation files miRNA.dat (published miRNA
data in EMBL format), mature.fa (mature miRNA se-
quences in FASTA format) and miRNA.dead (entries
removed from the database) are retrieved from the
miRBase FTP server (ftp://mirbase.org) for all miRBase re-
leases. Files are locally parsed to extract relevant annota-
tion for mature and precursor miRNAs (accession number,
name, sequence) and to determine relationships between
precursor and mature miRNA records (precursor parents,
mature products) in each release. Record annotation is
compared between subsequent releases, using accession
numbers as the unique identifier for miRNA records.
As accession numbers for mature miRNAs were introduced
only in release 6.0, files up to miRBase release 5.1 were
manually curated to match (later) accession numbers. For
each annotation change, an entry is created in a MySQL
table containing the type of change, the release of occur-
rence and a change event identifier, linking to a second
table holding the annotation for the miRNA record after
the change. The presented database allows quick querying
of the annotation history of any miRNA record and is
computationally nonintensive. The database can be
queried online at www.mirbasetracker.org.
Supplementary Data
Supplementary data are available atDatabase online.
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